SOURCE: SOHM, Inc.

February 15, 2011 15:12 ET

SOHM India Announces Purchase Order for Private Label Generic Pharmaceutical Products in Sri Lanka

BUENA PARK, CA--(Marketwire - February 15, 2011) - SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories announced today that SOHM, India has received confirmation of a purchase order to supply 10 different generic drug formulations in Sri Lanka. The 10 products range initially within a dosage group of tablets and capsules with other dosage forms to follow. The buyer has placed an initial assorted order for 2 million capsules/tablets which incorporates selected antibiotics, anti-hypertensive, antacids, proton pump inhibitors and anti-histamine in the form of tablets and capsules.

Shailesh Shah, President and CEO of SOHM, Inc., stated, "The Sri Lankan market is very accessible for our India based manufacturing operations. This close proximity allows us to supply our pharmaceutical products at very affordable and competitive price points in the region. Sri Lanka is considered a gateway to Southeast Asia and one of the fastest growing pharmaceutical markets in the world. We are positioning SOHM to be a major distributor of generic pharmaceuticals in this region."

Sri Lanka is ranked as the most liberalized economy in South Asia and is positioned as the Gateway to Asia, with its open economy and superior logistics for serving as a regional trade hub.

About SOHM, Inc.
SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    SOHM, Inc.
    Investor Relations
    (714) 522-6700
    Email Contact